Lai Wang
Förmögenhet: 52 M $ per 2026-05-31
Förmögenhet: 52 M $ per 2026-05-31
Lai Wang is President, Global Head-Research & Development at BeOne Medicines Ltd. since 2025.
Formerly, Mr. Wang was Director-Research at Joyant Pharmaceuticals, Inc. Education includes an undergraduate degree from Fudan University in 1996 and a doctorate from The University of Texas Health Science Center at Houston in 2001.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,16 % | 2026-06-23 | 2 295 785 ( 0,16 % ) | 52 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| BEIGENE LTD | President | 2025-12-17 |
| Företag | Position | Slut |
|---|---|---|
Joyant Pharmaceuticals, Inc.
Joyant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for cancer | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Joyant Pharmaceuticals, Inc.
Joyant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for cancer | Health Technology |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån